Stay updated with breaking news from Q4 Numbers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During the quarter, the net NPAs declined to 0.31 percent from 0.36 percent in the preceding quarter. Also, recoveries from written off accounts stood at Rs 919 crore.
Neogen Chemicals also has a slew of capacity expansion plans under the pipeline, with an estimated cost of around Rs 450 crore.
Despite the huge jump, Dr Reddy's net profit for the fourth quarter lagged Street's estimate and brokerages are concerned about the firm's growth map
An improved product mix also helped Lupin expand its EBIDTA margin for the quarter by 690 basis points on year.
Dr Reddy's is poised to reap the benefits of brand sales of Rs 275 crore, which will incrementally boost its headline numbers for Q4.